Company Overview of S*BIO Pte Ltd.
S*BIO Pte Ltd. provides research and clinical development services for small molecule drugs for the treatment of cancer in Singapore. The company’s products include JAK2 inhibitors, such as SB1518 for leukemia/myelofibrosis, lymphoma, and polycythemia; and SB1578 for RA/psoriasis. S*BIO Pte Ltd. also offers SB939, a histone deacetylases for MDS/AML+combo, prostate cancer, sarcoma, pediatric tumor, and myelofibrosis; SB2602, a mTOR inhibitor; SB2343, a mTOR/PI3K inhibitor; and SB1317, a CDK/Flt3 inhibitor. The company was founded in 2000 and is based in Singapore. S*BIO Pte Ltd. operates as a subsidiary of Chiron Corporation Limited.
1 Science Park Road
#05-09 The Capricorn
Singapore Science Park II
Founded in 2000
65 6827 5000
65 6827 5005
Key Executives for S*BIO Pte Ltd.
Similar Private Companies By Industry
|Attogenix Biosystems Pte Ltd||Asia|
|Biotech Research Ventures Pte. Ltd.||Asia|
|China Agro-Technology Holdings Ltd.||Asia|
|Clearbridge NanoMedics Pte Ltd.||Asia|
|Compass Foods Pte Ltd||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact S*BIO Pte Ltd., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.